Development of a TB vaccine trial site in Africa and lessons from the Ebola experience

• Main Authors: G. Kaguthi (Author), V. Nduba (Author), P. Rabuogi (Author), D. Okelloh (Author), S. G. Ouma (Author), G. Blatner (Author), S. Gelderbloem (Author), Ellen M. H. Mitchell (Author), Cherise P. Scott (Author), S. Verver (Author), T. Hawkridge (Author), J. E. M. de Steenwinkel (Author), K. F. Laserson (Author), J. H. Richardus (Author)
• Format: Book
• Published: BMC, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in mortality, there is now a vaccine licensed in the United States and by the European Medicines Agency, with up to 100% efficacy again...